Download PDFPDF

794 TKM-011, Anti-CD20 antibody confers multi-properties against burkitt’s lymphoma in comparable efficacy to rituximab and obinutuzumab
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address